Overview A Study Comparing PF-05089771 TS Capsule To PF-05089771 TS Oral Dispersion In The Fasted State Status: Completed Trial end date: 2012-09-01 Target enrollment: Participant gender: Summary The primary purpose of this study is to estimate the relative bioavailability and food effect of a PF-05089771 capsule. Phase: Phase 1 Details Lead Sponsor: Pfizer